AR065338A1 - Metodo para tratar o prevenir deterioro, lesion o dano de tejidos debido a enfermedad de las mucosas - Google Patents
Metodo para tratar o prevenir deterioro, lesion o dano de tejidos debido a enfermedad de las mucosasInfo
- Publication number
- AR065338A1 AR065338A1 ARP080100621A ARP080100621A AR065338A1 AR 065338 A1 AR065338 A1 AR 065338A1 AR P080100621 A ARP080100621 A AR P080100621A AR P080100621 A ARP080100621 A AR P080100621A AR 065338 A1 AR065338 A1 AR 065338A1
- Authority
- AR
- Argentina
- Prior art keywords
- disease
- injury
- damage
- mucose
- treat
- Prior art date
Links
- 230000006378 damage Effects 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 208000027418 Wounds and injury Diseases 0.000 title abstract 2
- 230000006866 deterioration Effects 0.000 title abstract 2
- 208000014674 injury Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000004744 fabric Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002519 immonomodulatory effect Effects 0.000 abstract 2
- 108010033276 Peptide Fragments Chemical group 0.000 abstract 1
- 102000007079 Peptide Fragments Human genes 0.000 abstract 1
- 101710188315 Protein X Chemical group 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- -1 heterocyclic amino acid Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000009467 reduction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90097707P | 2007-02-13 | 2007-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR065338A1 true AR065338A1 (es) | 2009-06-03 |
Family
ID=39690681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080100621A AR065338A1 (es) | 2007-02-13 | 2008-02-13 | Metodo para tratar o prevenir deterioro, lesion o dano de tejidos debido a enfermedad de las mucosas |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7906486B2 (OSRAM) |
| EP (1) | EP2120986A4 (OSRAM) |
| JP (1) | JP2010518160A (OSRAM) |
| KR (1) | KR20090119897A (OSRAM) |
| CN (1) | CN101657210A (OSRAM) |
| AR (1) | AR065338A1 (OSRAM) |
| AU (1) | AU2008216799A1 (OSRAM) |
| CA (1) | CA2677749A1 (OSRAM) |
| IL (1) | IL200364A0 (OSRAM) |
| MX (1) | MX2009008641A (OSRAM) |
| NZ (1) | NZ579570A (OSRAM) |
| TW (1) | TW200845958A (OSRAM) |
| UA (1) | UA96980C2 (OSRAM) |
| WO (1) | WO2008100458A2 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2677749A1 (en) * | 2007-02-13 | 2008-08-21 | Sciclone Pharmaceuticals, Inc. | Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa |
| RU2436587C1 (ru) * | 2010-10-21 | 2011-12-20 | Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") | N-изовалероил-l-глутамил-l-триптофан как средство, препятствующее язвообразованию в желудке и двенадцатиперстной кишке |
| CN109528202B (zh) * | 2018-11-14 | 2021-07-16 | 北京大学第一医院 | 一种头颈部放疗诊疗系统 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4125626A (en) * | 1977-01-17 | 1978-11-14 | Mt. Sinai School Of Medicine Of The City University Of New York | Synthesis and use of L-γ-glutamyl-DOPA |
| US4568489A (en) * | 1984-06-29 | 1986-02-04 | E. R. Squibb & Sons, Inc. | N-Acyl-γ-glutamyl imino and amino acids and esters |
| US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US4758551A (en) * | 1986-07-08 | 1988-07-19 | Cornell Research Foundation, Inc. | Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types |
| US4968672A (en) * | 1987-01-02 | 1990-11-06 | The United States Of America As Represented By The Department Of Health And Human Services | Adenosine receptor prodrugs |
| US4895835A (en) * | 1987-11-20 | 1990-01-23 | Nisshin Oil Mills, Ltd. | Muramyl peptide derivatives and use thereof |
| US5728680A (en) * | 1987-12-30 | 1998-03-17 | Cytoven J.V. | Methods for normalizing numbers of lymphocytes |
| US5902790A (en) * | 1995-10-03 | 1999-05-11 | Cytran, Inc. | Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
| US5206220A (en) * | 1990-04-23 | 1993-04-27 | Research Corporation Technologies, Inc. | Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition |
| WO1992017191A1 (en) | 1991-04-01 | 1992-10-15 | Cytoven | Pharmaceutical dipeptide compositions and methods of use thereof |
| WO1993008815A1 (en) | 1991-10-28 | 1993-05-13 | Cytoven | Pharmaceutical dipeptide compositions and methods of use thereof |
| WO1994020063A2 (en) | 1993-03-04 | 1994-09-15 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
| GB9320820D0 (en) * | 1993-10-08 | 1993-12-01 | Biokine Tech Ltd | Compounds for medicinal use |
| RU2107692C1 (ru) * | 1995-06-07 | 1998-03-27 | Дейгин Владислав Исакович | Пептид и способ его получения |
| US5888980A (en) * | 1994-06-30 | 1999-03-30 | Bio-Logic Research And Development Corporation | Compositions for enhancing immune function |
| US5916878A (en) * | 1995-11-28 | 1999-06-29 | Edward T. Wei | γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith |
| US5744452A (en) * | 1995-11-28 | 1998-04-28 | Edward T. Wei | γ-L-glutamyl containing immunomodulator compounds and methods therewith |
| RU2120298C1 (ru) | 1995-11-28 | 1998-10-20 | Товарищество с ограниченной ответственностью "Верта" | Иммуностимулятор и препарат на его основе |
| WO1997019691A1 (en) | 1995-11-28 | 1997-06-05 | Wei, Edward, T. | Gamma-l-glutamyl containing immunomodulator compounds and methods therewith |
| US6060452A (en) * | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
| RU2141483C1 (ru) | 1997-07-04 | 1999-11-20 | Небольсин Владимир Евгеньевич | Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция |
| US7173013B2 (en) * | 2001-06-08 | 2007-02-06 | Sciclone Pharmaceuticals, Inc. | Treatment of tuberculosis using immunomodulator compounds |
| RU2229892C2 (ru) | 2001-06-08 | 2004-06-10 | Государственное учреждение "Санкт-Петербургский научно-исследовательский институт фтизиопульмонологии" | Способ лечения туберкулеза легких |
| US20050256042A1 (en) * | 2003-05-09 | 2005-11-17 | Jeffers Michael E | Methods of preventing and treating alimentary mucositis |
| AU2005244826B2 (en) * | 2004-05-14 | 2010-07-29 | Sciclone Pharmaceuticals, Inc. | Treatment or prevention of respiratory viral infections with immunomodulator compounds |
| JP4874985B2 (ja) | 2004-10-27 | 2012-02-15 | サイクローン・ファーマシューティカルズ・インコーポレイテッド | 免疫調節化合物による出血性ウイルス感染の治療又は予防 |
| WO2006076169A2 (en) | 2004-12-28 | 2006-07-20 | Sciclone Pharmaceuticals, Inc. | Treatment or prevention of genital viral infections with immunomodulator compounds |
| US20090074815A1 (en) * | 2005-04-22 | 2009-03-19 | Sciclone Pharmaceuticals, Inc. | Immunomodulator Compounds as Vaccine Enhancers |
| AU2007240946A1 (en) * | 2006-04-20 | 2007-11-01 | Sciclone Pharmaceuticals, Inc. | Treatment of melanoma |
| JP2010513508A (ja) | 2006-12-18 | 2010-04-30 | アキリオン ファーマシューティカルズ，インコーポレーテッド | Ｃ型肝炎感染を処置するための併用療法 |
| CA2677749A1 (en) * | 2007-02-13 | 2008-08-21 | Sciclone Pharmaceuticals, Inc. | Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa |
| RU2007118237A (ru) | 2007-05-17 | 2008-11-27 | ООО "Научно-производственна фирма Верта" (RU) | Способ лечения аллергических заболеваний |
| US20110189305A1 (en) | 2007-08-23 | 2011-08-04 | Tuthill Cynthia W | Treatment of lung cancer |
| JP2011530519A (ja) | 2008-08-06 | 2011-12-22 | サイクローン・ファーマシューティカルズ・インコーポレイテッド | 免疫調節化合物を用いたｃ型肝炎の治療または予防の方法 |
-
2008
- 2008-02-11 CA CA002677749A patent/CA2677749A1/en not_active Abandoned
- 2008-02-11 US US12/526,585 patent/US7906486B2/en not_active Expired - Fee Related
- 2008-02-11 KR KR1020097018913A patent/KR20090119897A/ko not_active Withdrawn
- 2008-02-11 EP EP08725404A patent/EP2120986A4/en not_active Withdrawn
- 2008-02-11 MX MX2009008641A patent/MX2009008641A/es not_active Application Discontinuation
- 2008-02-11 UA UAA200909229A patent/UA96980C2/ru unknown
- 2008-02-11 NZ NZ579570A patent/NZ579570A/en not_active IP Right Cessation
- 2008-02-11 CN CN200880011935A patent/CN101657210A/zh active Pending
- 2008-02-11 JP JP2009549595A patent/JP2010518160A/ja not_active Withdrawn
- 2008-02-11 AU AU2008216799A patent/AU2008216799A1/en not_active Abandoned
- 2008-02-11 WO PCT/US2008/001768 patent/WO2008100458A2/en not_active Ceased
- 2008-02-13 AR ARP080100621A patent/AR065338A1/es not_active Application Discontinuation
- 2008-02-13 TW TW097105084A patent/TW200845958A/zh unknown
-
2009
- 2009-08-12 IL IL200364A patent/IL200364A0/en unknown
-
2011
- 2011-01-25 US US13/013,340 patent/US20110117211A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ579570A (en) | 2012-02-24 |
| EP2120986A4 (en) | 2010-04-07 |
| CA2677749A1 (en) | 2008-08-21 |
| KR20090119897A (ko) | 2009-11-20 |
| US20100086622A1 (en) | 2010-04-08 |
| WO2008100458A2 (en) | 2008-08-21 |
| AU2008216799A1 (en) | 2008-08-21 |
| MX2009008641A (es) | 2009-09-14 |
| EP2120986A2 (en) | 2009-11-25 |
| UA96980C2 (ru) | 2011-12-26 |
| IL200364A0 (en) | 2010-04-29 |
| TW200845958A (en) | 2008-12-01 |
| CN101657210A (zh) | 2010-02-24 |
| JP2010518160A (ja) | 2010-05-27 |
| US7906486B2 (en) | 2011-03-15 |
| WO2008100458A3 (en) | 2008-11-27 |
| US20110117211A1 (en) | 2011-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066653A (es) | Derivados de bencenosulfonilamino-piridin-2-il y compuestos relacionados como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1(ii-beta-hsd-1) para el tratamiento de la diabetes y de la obesidad | |
| AR075204A1 (es) | Inhibidores de dpp-4 y composiciones farmaceuticas que los comprenden, utiles para tratar enfermedades metabolicas en pacientes pediatricos, particularmente diabetes mellitus tipo 2 | |
| NO20065847L (no) | Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase | |
| CR11510A (es) | Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer | |
| CO6430453A2 (es) | Terapia de combinacion para el tratamiento de la diabetes | |
| NI200800169A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor | |
| RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
| AR060089A1 (es) | Tratamiento del dolor | |
| GT201200038A (es) | Composicion para tratar la fibrosis quistica | |
| UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
| AR047513A1 (es) | Metodos y composiciones para el tratamiento de cambios en la piel relacionados con el envejecimiento y los danos ocasionados por el medio ambiente | |
| ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
| NO20061625L (no) | Behandling og/eller forhindring av urininkontinens ved bruk av prolegemidler av gaba analoger | |
| AR084216A1 (es) | Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k e inhibidor de mek, kit | |
| AR087902A1 (es) | COMPOSICIONES Y METODOS PARA TRATAR EL CANCER USANDO EL INHIBIDOR DE PI3Kb Y EL INHIBIDOR DE LA VIA DE MAPK, INCLUIDOS LOS INHIBIDORES DE MEK Y RAF | |
| AR065338A1 (es) | Metodo para tratar o prevenir deterioro, lesion o dano de tejidos debido a enfermedad de las mucosas | |
| ECSP088545A (es) | Composición para prevenir o tratar daños de la mucosa en los conductos gastrointestinales | |
| WO2012135597A3 (en) | Novel, protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair | |
| UY30557A1 (es) | Tratamiento y prevencion de la fibrosis intestinal | |
| CO2023004447A2 (es) | Composiciones y métodos para el tratamiento de distrofias musculares | |
| CL2021003303A1 (es) | Tratamiento para sinucleinopatías. | |
| MX2009012297A (es) | Composiciones para el tratamiento de enfermedad alergica, con compuestos inmunoreguladores. | |
| ES2555785T3 (es) | Remedio o preventivo para esquizofrenia | |
| HRP20041150A2 (en) | Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women | |
| CU20130004A7 (es) | Agentes terapéuticos 976 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |